@article {poordad2019daclatasvir,
	title = {Daclatasvir and sofosbuvir with ribavirin for 24 weeks in chronic hepatitis C genotype-3-infected patients with cirrhosis: a Phase III study (ALLY-3C)},
	journal = {Antivir Ther},
	volume = {24},
	number = {1},
	year = {2019},
	pages = {35{\textendash}44},
	author = {Poordad, Fred and Shiffman, Mitchell L and Ghesquiere, Wayne and Wong, Alexander and Huhn, Gregory D and Wong, Florence and Ramji, Alnoor and Shafran, Stephen D and McPhee, Fiona and Yang, Rong and others}
}
